Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Annals of Surgical Oncology

01-06-1998 | Original Articles

Localized well-differentiated thyroid carcinoma: Survival analysis of prognostic factors and131I therapy

Authors: Don M. Morris, MD, Patrick J. Boyle, MD, Christine A. Stidley, PhD, Kathleen K. Altobelli, MS, Teresa Parnell, CTR, Charles Key, MD

Published in: Annals of Surgical Oncology | Issue 4/1998

Login to get access
Metadata
Title
Localized well-differentiated thyroid carcinoma: Survival analysis of prognostic factors and131I therapy
Authors
Don M. Morris, MD
Patrick J. Boyle, MD
Christine A. Stidley, PhD
Kathleen K. Altobelli, MS
Teresa Parnell, CTR
Charles Key, MD
Publication date
01-06-1998
Publisher
Springer-Verlag
Published in
Annals of Surgical Oncology / Issue 4/1998
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1007/BF02303496